Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-19

Clinical Trial Update: The Effect of Roxadustat on Renal Oxygenation in Diabetes Nephropathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Roxadustat's effect on renal oxygenation in patients with diabetic nephropathy; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Roxadustat (roxadustat)

Snippet

Sponsor: Region Stockholm | Conditions: Diabetes Complications, Diabetes; Nephropathy (Manifestation) | Phase 2 | Status: NOT_YET_RECRUITING